Published on 01/07/2021
At the end of January 2018, I was approached by a Central European public authority to assist with the implementation of the clean-up of a large HCH waste site at a former lindane production facility. My task was specifically to assess the technical scope of the tender documents, i.e. the framework for the implementation of the project by the successful contractor. After reviewing my files and the cases I had been involved in, including my compilation of HCH case examples, I could see that much of the available information was outdated, and for many of the cases with high-level descriptions only. So, despite all my 30 years’ experience, I lacked proper, well-documented records about the detailed problems which I knew would occur on the site of my client during clean-up.
The situation was not new to me. HCH sites are some of the most complicated and costly sites to analyze and clean up. Sharing information on HCH-contaminated sites is therefore not top of the list of problems faced by owners, whether public authorities or private companies. Yet these are sites where both human health and the environment are under significant risk.
Contact with Novartis
At the time of my new assignment, I already knew about the clean-up at Novartis through the STEIH newsletters, and I had already been in contact in February 2018. They kindly provided me with technical data on the extent and cost of their clean-up activities at the STEIH site. The information was to be disclosed in a report I was planning to publish with colleagues about the extent of the HCH problem in the member states of the European Union.
On that basis, I wrote a request to Novartis at the end of November 2018 to discuss the possibility for a technical exchange on all the expected practical issues my client would face during his project. We were mainly interested in specific implementation approaches for odor and dust emissions and the experiences made with environmental enclosures (i.e. tents around the excavation works). We hoped to transfer specific experiences and possibly also new developments in work approaches. A whole lot of “hot and not always pleasant issues” were highlighted, such as:
– How do we ensure we have adequate information on the contamination to guarantee the remediation project is efficiently executed?
– How would we ensure that we avoid a contract being awarded to a party with insufficient knowledge of the complexity and severity of HCH problems?
– How can we manage dust and odor emissions of HCH and degradation products, an area with very little published experience?
– How can we most efficiently communicate with project stakeholders?
To be honest, I had expected a standard politely written excuse that such a technical exchange would not be possible. But I was proven wrong! At the beginning of January 2019, I received a message from Novartis that they were willing to share their experiences and were open to discuss all issues on our list. Our discussions were held shortly afterwards on-site at a two-day meeting with representatives of Novartis, the consultant company and the contractor, along with my Central European client and myself. During these two days we received every possible input, and everyone involved showed a genuine interest in assisting my client and me as much as possible by sharing their own experiences. This was much more than we could have expected.